IP Library Granted Patent US 7,323,299
Granted Patent B2
US 7,323,299 · App. 10/239,288 · Granted Jan 29, 2008

Methods for in vivo diversification of single genes

Assignee: Neugenesis Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,323,299
App. No.
10/239,288
Granted
Jan 29, 2008
Kind
B2
Abstract

Methods and compositions are provided for the efficient in vivo diversification of gene-products in filamentous fungi, starting from (but not limited to) two or more copies of a single gene constituent. The diversification involve use of the Repeat-Induced Point mutation (RIP) process in N. crassa , and other fungi that have analogous mutational processes. The invention takes advantage of the induction of G:C to A:T transition mutations specific to duplicated DNA sequences during the premeiotic dikaryon phase of the life cycle of the fungus. The methods and compositions of the invention can be utilized to generate diversity in target genes, and are proposed for the purpose of altering and generating novel forms and activities of gene-products thus encoded. Duplicated genes may be introduced into the organism and are present either in tandem, or at separate ectopic locations within the genome of the fungus. After crossing the resulting transformant(s), sexual progeny can then be selected which contain the mutated gene, and subsequently screened for a desired product.

Claims (9)

1. A method for diversifying an initial target polynucleotide sequence comprising:

introducing two or more copies of said initial sequence into a filamentous fungal cell wherein at least two identical copies are tandemly linked;

generating a population of diversified sequences which are diversified relative to the initial target sequence by culturing the filamentous fungal cell under conditions that promote premeiotic mutation and/or recombination; and

selecting said diversified sequence is functionally active, wherein the initial target polynucleotide sequence is exogenous to the filamentous fungal cell.

2. The method of claim 1 wherein said mutation is RIP mutation.

3. The method of claim 1 wherein said sequence encodes an active gene product, regulates the expression of other sequences, or serves a structural role.

4. The method of claim 1 wherein said cell is selected from the groups Phycomycetes, Ascomycetes , and Basidiomycetes.

5. The method of claim 4 wherein said cell is selected from the group consisting of Neurospora, Penicillium, Fusarium, Gelasinospora, Ascobolus, Podospora , and Magnaporthe.

6. The method of claim 5 wherein said cell is selected from the group consisting of N. intermedia, N. crassa, N. sitophila , and N. etrasperma.

Assignments (3)
CHANGE OF NAME Recorded Aug 23, 2012
From: NEUGENESIS CORPORATION
To: BYTC CORPORATION
Reel/Frame 028835/0819 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2012
From: BYTC CORPORATION
To: INTREXON CORPORATION
Reel/Frame 028835/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2007
From: CAMBARERI, EDWARD B.; KATO, ELI E.
To: NEUGENESIS CORPORATION
Reel/Frame 019335/0781 →
Continuity (2)
Provisional Application 6019093900 · Mar 21, 2000
Related Publication 20030215933A1 · Nov 20, 2003